Singapore markets close in 1 hour 24 minutes
  • Straits Times Index

    3,075.56
    -45.02 (-1.44%)
     
  • Nikkei

    27,821.76
    -462.16 (-1.63%)
     
  • Hang Seng

    23,457.95
    -394.29 (-1.65%)
     
  • FTSE 100

    7,109.95
    +65.92 (+0.94%)
     
  • BTC-USD

    56,481.07
    -1,174.72 (-2.04%)
     
  • CMC Crypto 200

    1,426.41
    -2.52 (-0.18%)
     
  • S&P 500

    4,655.27
    +60.65 (+1.32%)
     
  • Dow

    35,135.94
    +236.60 (+0.68%)
     
  • Nasdaq

    15,782.83
    +291.18 (+1.88%)
     
  • Gold

    1,792.80
    +7.60 (+0.43%)
     
  • Crude Oil

    67.82
    -2.13 (-3.05%)
     
  • 10-Yr Bond

    1.5300
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,513.12
    +2.55 (+0.17%)
     
  • Jakarta Composite Index

    6,580.14
    -28.15 (-0.43%)
     
  • PSE Index

    7,200.88
    -77.56 (-1.07%)
     

Europe Gastroparesis Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Market Valuations, Drug Sales, Drug Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

·3-min read

DUBLIN, October 21, 2021--(BUSINESS WIRE)--The "Europe Gastroparesis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Europe Gastroparesis Market and Competitive Landscape - 2021, provides comprehensive insights into Gastroparesis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.

This research analyzes and forecasts Gastroparesis market size and drug sales. It also provides insights into Gastroparesis epidemiology and late-stage pipeline.

This research covers the following - Gastroparesis treatment options, Gastroparesis late-stage clinical trials pipeline, Gastroparesis prevalence by countries, Gastroparesis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

  • Countries: Germany, France, Italy, Spain, UK, Europe

  • Gastroparesis pipeline: Find out drugs in clinical trials for the treatment of Gastroparesis by development phase 3, phase 2, by pharmacological class and company

  • Gastroparesis epidemiology: Find out the number of patients diagnosed (prevalence) with Gastroparesis by countries

  • Gastroparesis drugs: Identify key drugs marketed and prescribed for Gastroparesis in the US, including trade name, molecule name, and company

  • Gastroparesis drugs sales: Find out the sales value for Gastroparesis drugs by countries

  • Gastroparesis market valuations: Find out the market size for Gastroparesis drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026

  • Gastroparesis drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

  • Evaluate commercial market opportunities for Gastroparesis drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in Gastroparesis market

  • Develop in-depth knowledge of competition and markets

  • Analyze Gastroparesis drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in Gastroparesis market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Gastroparesis Treatment Options

2. Gastroparesis Pipeline Insights

2.1. Gastroparesis Phase 3 Clinical Trials

2.2. Gastroparesis Phase 2 Clinical Trials

2.3. Gastroparesis Phase 1 Clinical Trials

3. Gastroparesis Epidemiology Analysis by Countries

4. Germany Gastroparesis Market Insights

4.1. Marketed Drugs for Gastroparesis in Germany

4.2. Germany Gastroparesis Market Size & Forecast

4.3. Germany Gastroparesis Drugs Sales Forecast

4.4. Germany Gastroparesis Market Share Analysis

5. France Gastroparesis Market Insights

6. Italy Gastroparesis Market Insights

7. Spain Gastroparesis Market Insights

8. UK Gastroparesis Market Insights

9. Europe Gastroparesis Market Insights

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/11ml40

View source version on businesswire.com: https://www.businesswire.com/news/home/20211021005585/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting